Hostname: page-component-7c8c6479df-ws8qp Total loading time: 0 Render date: 2024-03-29T16:02:38.262Z Has data issue: false hasContentIssue false

A Clinical review about differential diagnosis and comorbidities on premenstrual dysphoric disorder

Published online by Cambridge University Press:  23 March 2020

L. Sánchez Blanco
Affiliation:
Hospital universitario Marqués de Valdecilla, psychiatry, Santander, Spain
M. Juncal Ruíz
Affiliation:
Hospital universitario Marqués de Valdecilla, psychiatry, Santander, Spain
G. Pardo de Santayana Jenaro
Affiliation:
Hospital universitario Marqués de Valdecilla, psychiatry, Santander, Spain
R. Landera Rodríguez
Affiliation:
Hospital universitario Marqués de Valdecilla, psychiatry, Santander, Spain
M. Gómez Revuelta
Affiliation:
Hospital universitario de Álava-sede Santiago, psychiatry, Vitoria-Gasteiz, Spain
O. Porta Olivares
Affiliation:
Hospital universitario Marqués de Valdecilla, psychiatry, Santander, Spain
N.I. Núñez Morales
Affiliation:
Hospital universitario de Álava-sede Santiago, psychiatry, Vitoria-Gasteiz, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Symptoms of premenstrual dysphoric disorder (PMDD) recur during the premenstrual phase of the cycle and disappear to the beginning or after last menstruation. The main symptoms are emotional liability, dysphoria and anxiety.

Objectives

To review PMDD for helping in the differential diagnosis between this disease and classical anxiety disorders.

Methods

It was made a clinical review about differential diagnosis and comorbilities on PMDD in specialized literature and Pub-Med.

Results

PMDD causes significant distress and impairment in social or occupational functioning the first week following menstruation. In relation with differential diagnosis on PMDD, on the one hand, several organic diseases could produce the same symptoms than PMDD: for example gynecological pathology as dysmenorrhea or menopausal transition, endocrinological diseases as hypothyroidism and hyperthyroidism and some hormonal treatment including hormonal contraceptives. In addition, a variety of medical disorders are concomitant pathologies that could be associated with PMDD (eg, migraine; epilepsy, asthma, allergies, systemic exertion intolerance disease, chronic fatigue syndrome; irritable bowel syndrome). These pathologies are exacerbated just before or during menstruation. On the other hand, several psychiatric disorders as bipolar disorder, major depression, dystimia, and anxiety disorders could get worse on the premenstrual phase.

Conclusions

In relation with the diagnosis of PMDD, it seems necessary to consider various differential diagnosis such as psychiatric, gynecological and endocrine disorders because of all of them share like symptoms. For this purpose it is very important to make both a good clinical history and a comprehensive physical examination to offer the most accurate diagnosis and treatment.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
e-Poster viewing: Comorbidity/dual pathologies
Copyright
Copyright © European Psychiatric Association 2017
Submit a response

Comments

No Comments have been published for this article.